Oropouche Virus Exposure in Febrile Patients during Chikungunya Virus Introduction in the State of Amapá, Amazon Region, Brazil

• Published in: Pathogens (Basel) 2024-06, Vol.13 (6), p.469
• Main Authors: de Lima, Raquel Curtinhas, Dias, Helver Gonçalves, de Souza, Thiara Manuele Alves, Familiar-Macedo, Débora, Ribeiro, Edcelha D'Athaide, Corrêa, Valmir Corrêa E, Pauvolid-Corrêa, Alex, de Azeredo, Elzinandes Leal, Dos Santos, Flávia Barreto
• Format: Article
• Language: English
• Subjects: Antibodies; arbovirus; Asymptomatic; Chikungunya virus; Dengue fever; Disease transmission; Epidemics; Exposure; Immunoglobulin G; Immunoglobulin M; Infections; Neutralization; Neutralizing; PRNT; RT-qPCR; Serology; Signs and symptoms; surveillance; Vector-borne diseases; Viruses
• ISSN: 2076-0817; 2076-0817
• DOI: 10.3390/pathogens13060469

(OROV) is an arbovirus transmitted by midges that has been involved in outbreaks throughout Central and South America. In Brazil, human cases have been historically concentrated in the northern region of the country. Oropouche fever in humans range from mild clinical signs to rare neurological events, and is considered a neglected tropical disease in Brazil. Due to the clinical similarities to other arboviruses, such as chikungunya and dengue viruses, OROV infections are likely to be underreported. Chikungunya virus (CHIKV) cases in Brazil were first recognized in 2014 in the states of Amapá and Bahia in the north and northeast regions, respectively. Both OROV and CHIKV cause nonspecific symptoms, making clinical diagnosis difficult in a scenario of arbovirus cocirculation. Aiming to investigate OROV transmission during the CHIKV introduction in the state of Amapá located in the Brazilian Amazon, we conducted a retrospective molecular (RT-qPCR) and serological investigation in febrile cases (N = 166) collected between August 2014 and May 2015. All acute serum samples were negative for OROV RNA using RT-qPCR. However, neutralizing antibodies for OROV were detected using a plaque reduction neutralization test (PRNT ) in 10.24% (17/166) of the patients, with neutralizing antibody titers ranging from 20 to ≥640, suggesting the previous exposure of patients to OROV. Regarding CHIKV, recent exposure was confirmed by the detection of CHIKV RNA in 20.25% (33/163) of the patients and by the detection of anti-CHIKV IgM in 28.57% (44/154) of the patients. The additional detection of anti-CHIKV IgG in 12.58% (19/151) of the febrile patients suggests that some individuals had been previously exposed to CHIKV. Whether the OROV exposure reported here occurred prior or during the CHIKV circulation in Amapá, is unknown, but because those arboviral infections share similar clinical signs and symptoms, a silent circulation of enzootic arboviruses during the introduction of exotic arboviruses may occur, and highlights the importance of syndromic cases' surveillance to arboviruses in Brazil.